ERBB2 and breast carcinoma: HER2-negative breast cancer was identified by either the absence of HER2 protein staining (IHC 0); incomplete HER2 staining (IHC 1+); or moderate staining (IHC 2+) and negative testing for HER2 amplification by ISH.